SOURCE: Market Pulse

March 29, 2005 08:40 ET

Stocks to Watch for Tuesday, March 29, 2005: BOCX - Abbott and BioCurex Enter Into Agreement for RECAF™ Cancer Technology!

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Market Pulse.

ATLANTA, GA -- (MARKET WIRE) -- March 29, 2005 -- Market Pulse is pleased to introduce our featured stock, BioCurex, Inc. (OTC: BOCX), to the investment community! BioCurex is new to Market Pulse and is poised to become a significant player in the biotechnology industry! BOCX had great news out in a press release before today's opening bell regarding Abbott and BioCurex today announcing they have entered into a licensing agreement for BioCurex's RECAF™ material and technology! Investors should be watching this one closely! Other notable stocks that look great lately from a fundamental and technical perspective include:

Eltek Ltd (NASDAQ: ELTK) : Market Outperform

Largo Vista Group Ltd. (OTC BB: LGOV) : Attractive

Pfizer Inc. (NYSE: PFE) : Bearish

Recommendation Meanings

These recommendations are investment opinions of and reflect the stock's potential to move over the next one to four weeks of trading. This analysis is done from a technical and fundamental perspective.

After Monday's Bell Market Commentary

On Monday, the markets closed in the positive as oil prices retreated to settle at $54.05 a barrel. The contract traded as low as $53.60 a barrel during the session. The Dow Jones Industrial Average closed up 42.78 points, or 0.4 percent, at 10,485. The Nasdaq Composite gained 1.46 points to finish at 1,992.52 and the S&P 500 rose 2.86 points, or 0.2 percent, to 1,174.28.The Russell 2000 Index held steady at 615.


Market Pulse is a leading investor relations firm whose primary focus is promoting awareness among brokers, investors, and others in the investment community who are interested in small and micro-cap companies. Market Pulse is dedicated to helping publicly traded companies gain the exposure they need to move forward with the development of their business plans. Market Pulse's goal is to feature equity investments in micro or small capitalization companies that have the potential for long-term appreciation. Market Pulse provides investors with a complete suite of online interactive financial data and tools that includes quotes, charts, company profiles, news, market commentary and SEC filings, just to name a few. Market Pulse offers a free financial newsletter. To subscribe or get more information, visit our home page located at

Information contained herein is the opinion of ("MP") and is intended to be used strictly for informational purposes. You should be aware that MP attempts to assure itself of the accuracy of the information contained in the analyses it publishes. In this regard, MP does, at times, rely on the accuracy of information supplied to it by the companies which are the subject of MP's analyses and/or parties related to those companies. MP also relies on the accuracy and integrity of information that is contained in company press releases and reports filed with the SEC. The companies mentioned in this publication have not approved the content or timing of the information being published unless otherwise noted.

MP, because it relies on information supplied by various third parties disclaims any responsibility for the accuracy of such information. Any investor considering making an investment in any security which has been the subject of a MP analysis or opinion should, before making any such investment, consult with his/her market professional and/or do his/her own independent research regarding the company which is the subject of an MP opinion, recommendation or analysis. Information regarding companies which MP has opined upon is normally available from many sources including the subject company's filings with the SEC and various press releases issued by the company. You should be aware that MP is often compensated for issuing analyses, recommendations or opinions concerning particular companies. Its opinion is therefore not unbiased and you should consider this factor when evaluating MP's statements regarding a company. MP has been compensated twenty five thousand dollars from a third party shareholder for its coverage of BioCurex, Inc. MP also has fifty thousand restricted shares pending from BioCurex, Inc. In addition, MP in the open market previously purchased ten thousand shares of stock in BioCurex, Inc. for a total purchase price of fourteen thousand eighty dollars. To date, MP has sold zero shares. MP's officers and directors reserve the right to buy additional shares of the companies discussed in this opinion and may profit in the event those shares rise in value. When MP receives free trading shares as compensation for a profiled company, MP may sell part or all of any such shares during the period in which MP is performing such services.

Contact Information